Genetic mutations: Identifies mutations in the KRAS gene, which are important indicators in certain cancers, such as colon and lung cancer. Treatment response prediction: Helps evaluate the effectiveness of targeted therapies, as mutations may determine whether the treatment will be successful. Cancer diagnosis: Can assist in confirming the diagnosis of certain tumor types.

Patients diagnosed with colon cancer: To identify mutations that may influence treatment options. Patients with non-small cell lung cancer: The test helps guide targeted therapy. Individuals with other types of cancer: Such as pancreatic cancer, where KRAS mutations may be associated with disease progression. Patients undergoing chemotherapy: To assess the potential effectiveness of targeted therapies based on the gene status.

Colon cancer symptoms: Such as rectal bleeding, abdominal pain, and changes in bowel habits. Lung cancer symptoms: Such as persistent cough, shortness of breath, and unexplained weight loss. Pancreatic cancer symptoms: Such as upper abdominal pain, loss of appetite, and jaundice. Family history of cancer: Especially if there is a history of cancers associated with the KRAS gene.

How is the analysis performed? A sample of tumor tissue or a blood sample is taken from the patient. Does the analysis require fasting? Typically, fasting is not necessary, but it is advisable to check with the doctor. How long does it take to get the results? Results may be available within one to two weeks, depending on the laboratory. What are the risks associated with the analysis? The risks are minimal, but discomfort may occur when the sample is taken. What do positive results mean? Positive results may indicate mutations in the KRAS gene, which could affect treatment options. Can the results be negative despite symptoms? Yes, some cases may occur without KRAS mutations, so it's important to monitor symptoms with a doctor. Does the analysis affect treatment options? Yes, the analysis helps guide treatment options, especially targeted therapies.

KRAS analysis does not determine traditional “normal” levels; it focuses on the presence or absence of mutations in the gene. Results: Positive: KRAS gene mutations are present. Negative: No mutations detected. Positive: KRAS gene mutations are present. Negative: No mutations detected. Interpreting results: Negative result: No mutations found, which may indicate different treatment options. Positive result: Mutations are present, potentially influencing the treatment plan and determining suitable targeted therapies. Negative result: No mutations found, which may indicate different treatment options. Positive result: Mutations are present, potentially influencing the treatment plan and determining suitable targeted therapies.

KRAS Gene Mutation Test | Lahalak Medical

An advanced genetic test to detect KRAS mutations, helping identify appropriate treatments for cancer patients and guiding the therapeutic plan with high precision and effectiveness.

Prices starts from: 798.84 SAR

Scientific name: KRAS Gene Mutation Test

The KRAS test (KRAS Gene Analysis) is a genetic test used to detect mutations in the KRAS gene, which plays a crucial role in regulating cell growth and proliferation. This test is an important tool in evaluating certain types of cancer, such as colorectal cancer and lung cancer, as mutations in this gene can help determine the most appropriate tre...

KRAS Gene Mutation Test - KRAS Gene Mutation Analysis

Service type Genetic test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 798.84 SAR

Included Services

KRAS Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Genetic mutations: Identifies mutations in the KRAS gene, which are important indicators in certain cancers, such as colon and lung cancer.
Treatment response prediction: Helps evaluate the effectiveness of targeted therapies, as mutations may determine whether the treatment will be successful.
Cancer diagnosis: Can assist in confirming the diagnosis of certain tumor types.

Recommended groups

Patients diagnosed with colon cancer: To identify mutations that may influence treatment options.
Patients with non-small cell lung cancer: The test helps guide targeted therapy.
Individuals with other types of cancer: Such as pancreatic cancer, where KRAS mutations may be associated with disease progression.
Patients undergoing chemotherapy: To assess the potential effectiveness of targeted therapies based on the gene status.

Symptoms indicative

Colon cancer symptoms: Such as rectal bleeding, abdominal pain, and changes in bowel habits.
Lung cancer symptoms: Such as persistent cough, shortness of breath, and unexplained weight loss.
Pancreatic cancer symptoms: Such as upper abdominal pain, loss of appetite, and jaundice.
Family history of cancer: Especially if there is a history of cancers associated with the KRAS gene.

FAQs

How is the analysis performed? A sample of tumor tissue or a blood sample is taken from the patient.
Does the analysis require fasting? Typically, fasting is not necessary, but it is advisable to check with the doctor.
How long does it take to get the results? Results may be available within one to two weeks, depending on the laboratory.
What are the risks associated with the analysis? The risks are minimal, but discomfort may occur when the sample is taken.
What do positive results mean? Positive results may indicate mutations in the KRAS gene, which could affect treatment options.
Can the results be negative despite symptoms? Yes, some cases may occur without KRAS mutations, so it's important to monitor symptoms with a doctor.

Normal Levels

KRAS analysis does not determine traditional “normal” levels; it focuses on the presence or absence of mutations in the gene.
Results: Positive: KRAS gene mutations are present. Negative: No mutations detected.
Positive: KRAS gene mutations are present.
Negative: No mutations detected.
Interpreting results: Negative result: No mutations found, which may indicate different treatment options. Positive result: Mutations are present, potentially influencing the treatment plan and determining suitable targeted therapies.
Negative result: No mutations found, which may indicate different treatment options.

Conditions & Notices

The terms and conditions announced on the "Lahalak" medical platform apply.
There are no special conditions for the service other than those mentioned.

KRAS Gene Mutation Test | Lahalak Medical

Included Services

Medical Service Information

Purpose Test

Recommended groups

Symptoms indicative

FAQs

Normal Levels

Conditions & Notices

Medical services you might also like

Blood Cell Mutation Test

Thymine Test for DNA Health

Body Energy & Metabolism Profile

Fatty Acid Disorders Profile